Amalgamated Bank Celularity Inc Transaction History

Amalgamated Bank

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$0.56 - $1.15 $137 - $281	-245 Reduced 2.4%	9,980 $6,000
Q3 2022 Nov 09, 2022	BUY	$0.43 - $4.31 $2,586 - $25,924	6,015 Added 142.87%	10,225 $24,000
Q2 2022 Aug 15, 2022	BUY	$2.81 - $12.91 $11,830 - $54,351	4,210 New	4,210 $14,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.